Obstetrics and gynecology
-
Obstetrics and gynecology · Nov 2019
Decreasing Opioid Use Postpartum: A Quality Improvement Initiative.
To estimate the effects of an inpatient initiative to decrease opioid use among women admitted to labor and delivery. ⋯ A standardized multimodal pain power plan reduced opioid use among a large cohort of women admitted to labor and delivery in Central Texas. Despite meeting functional goals, some women reported increased pain during their hospital stay.
-
Obstetrics and gynecology · Nov 2019
EditorialTelemedicine Companies Providing Prescription-Only Medications: Pros, Cons, and Proposed Guidelines.
In the past few years, there has been a significant increase in the number of direct-to-consumer telehealth companies offering prescription medications to women. Leveraging technology, these companies have the potential to improve access to care and ensure that women have access to prescription-only medications in a convenient fashion. However, it is important to ensure that they are doing so in a safe, patient-centered way that observes evidence-based prescribing guidelines. In this article, we discuss the pros and cons of direct-to-consumer telehealth companies offering prescription medicine and suggest several guidelines to ensure that women are being cared for in an appropriate way.
-
Obstetrics and gynecology · Oct 2019
Use of Asynchronous Video Interviews for Selecting Obstetrics and Gynecology Residents.
To assess the effect of using of asynchronous video interviewing as a screening tool for obstetrics and gynecology residency selection. ⋯ Video interviewing may have promise as a tool for program directors to use to select candidates from a competitive applicant pool by measuring important noncognitive skills. Acceptance by obstetrics and gynecology applicants was mixed.
-
Obstetrics and gynecology · Oct 2019
ReviewPregnancy and the Postpartum Period as an Opportunity for Cardiovascular Risk Identification and Management.
Cardiovascular disease (CVD) is the leading cause of death in women. Because women generally present with more atypical symptoms of CVD than do men and because underlying CVD risk factors are often present for years before the onset of CVD, it is important to use innovative ways to identify women who should undergo CVD risk screening at a younger age. Pregnancy and the postpartum period afford us that opportunity, given that the development of certain pregnancy complications (hypertensive disorders of pregnancy, gestational diabetes, preterm birth, delivery of a neonate with fetal growth restriction, and significant placental abruption) can reliably identify women with underlying, often unrecognized, CVD risk factors. ⋯ Longer-term follow-up and recommendations should be individualized based on findings and risks. There is also an opportunity for future pregnancy counseling and discussion about the importance of weight loss between pregnancies, initiation of a routine involving physical activity, use of preconception folic acid, and the potential initiation of low-dose aspirin for those women at risk for future preeclampsia and fetal growth restriction or the use of progesterone for women at risk for preterm labor. The link between pregnancy complications and future CVD affords us with the earliest opportunity for CVD risk assessment for health preservation and disease prevention.